Anaplastic Large Cell Lymphoma
📧 Sign up to get email alerts when something new happens for Anaplastic Large Cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma [Phase 1]
A Phase 1 trial evaluating genetic testing-guided irinotecan therapy in patients with solid tumors or lymphoma; the study status is complete…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: MS-275 and Isotretinoin in Treating Patients With Metastatic or Advanced Solid Tumors or Lymphomas [Phase 1]
This Phase 1 trial evaluated entinostat (MS-275) plus isotretinoin in adults with metastatic or advanced solid tumors or various lymphomas; …
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: 506U78 in Treating Patients With Lymphoma [Phase 2]
Phase 2 clinical trial update on the agent 506U78 for various lymphomas; the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-29Clinical Trial Update: UCN-01 (7-Hydroxystaurosporine) to Treat Relapsed T-Cell Lymphomas [Phase 2]
Phase 2 trial of UCN-01 (7-Hydroxystaurosporine) for relapsed T-cell lymphomas was terminated, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-04-20Clinical Trial Update: Lenalidomide Therapy for Patients With Relapsed and/or Refractory, Peripheral T-Cell Lymphomas [EARLY_Phase 1]
An early-phase 1 study of lenalidomide in relapsed and/or refractory peripheral T-cell lymphomas was terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma [Phase 2]
Phase 2 clinical trial evaluating tipifarnib in relapsed or refractory lymphoma has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: A Phase 2 Open Label Trial of Brentuximab Vedotin (SGN-35) for Systemic Anaplastic Large Cell Lymphoma [Phase 2]
Phase 2 open-label trial evaluating Brentuximab Vedotin in systemic anaplastic large cell lymphoma, with results posted after completion.
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma [Phase 2]
The National Cancer Institute completed a Phase 2 trial of tanespimycin (17-AAG) in relapsed or refractory Anaplastic Large Cell Lymphoma, M…
-
CLINICAL_TRIALS withdrawal · 2010-04-26Clinical Trial Update: MDX-060 in Patients With Relapsed or Refractory Classic Systemic or Primary Cutaneous Anaplastic Large Cell Lymphoma [Phase 2]
This Phase 2 trial evaluating MDX-060 in relapsed or refractory anaplastic large cell lymphoma (systemic and primary cutaneous) has been wit…